Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line

Decorin, the prototype of an expanding family of small leucine-rich proteoglycans, is involved in a number of cellular processes including matrix assembly, fibrillogenesis and the control of cell proliferation. In this study, we investigated the role of decorin in suppressing tumor aggressiveness and bone metastases. We used a metastatic breast cancer cell line, MDA-MB-231, to show that decorin causes marked growth suppression bothin vitro and in vivo. A cytomegaloviral vector containing the decorin transgene caused greatly reduced cell growth, motility and observed metastases. Bone metastases were decreased by >90% upon decorin transfection. These results demonstrate a novel role for decorin in the reduction or prevention of tumor metastases in this breast cancer model and could eventually lead to improved therapies for metastatic breast cancer.

[1]  T. Fehm,et al.  A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.

[2]  B F Boyce,et al.  Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. , 1995, Cancer research.

[3]  S. Mercadante Malignant bone pain: pathophysiology and treatment , 1996, Pain.

[4]  J. Korenberg,et al.  The Human Lumican Gene , 1995, The Journal of Biological Chemistry.

[5]  A. Gulino,et al.  Transforming growth factor‐β1 enhances the invasiveness of human MDA‐MB‐231 breast cancer cells by up‐regulating urokinase activity , 1998 .

[6]  M. Pike,et al.  Hormonal chemoprevention of cancer in women , 1993, Science.

[7]  R. Iozzo,et al.  The role of decorin in collagen fibrillogenesis and skin homeostasis , 2002, Glycoconjugate Journal.

[8]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[9]  C. Restall,et al.  Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. , 2005, Molecular cancer research : MCR.

[10]  G. Hortobagyi,et al.  Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Nesland,et al.  Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1 , 2004, Clinical Cancer Research.

[12]  X. Zang,et al.  The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells. , 2002, Anticancer research.

[13]  Andrei V Bakin,et al.  Role of high‐molecular weight tropomyosins in TGF‐β‐mediated control of cell motility , 2008, International journal of cancer.

[14]  L C Murphy,et al.  Lumican and decorin are differentially expressed in human breast carcinoma , 2000, The Journal of pathology.

[15]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[16]  M. Weller,et al.  Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model , 2004, Cancer Gene Therapy.

[17]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Boyle,et al.  Pathophysiology and Treatment , 2000 .

[19]  Peter H Watson,et al.  Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  R. Iozzo,et al.  In vivo selective and distant killing of cancer cells, using adenovirus‐mediated decorin gene transfer , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  G. Mundy Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[22]  Paul J. Williams,et al.  Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma , 2000, Cancer.

[23]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[24]  P. Clézardin,et al.  Mechanisms of Bisphosphonate Effects on Osteoclasts, Tumor Cell Growth, and Metastasis , 2002, American journal of clinical oncology.

[25]  L. Lanier,et al.  TREM2, a DAP12‐Associated Receptor, Regulates Osteoclast Differentiation and Function , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  L. Lanier,et al.  The Signaling Adapter Protein DAP12 Regulates Multinucleation During Osteoclast Development , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  R. Iozzo,et al.  Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin , 2002, Oncogene.

[28]  T. Yoneda,et al.  Osteolytic bone metastasis in breast cancer , 2004, Breast Cancer Research and Treatment.

[29]  Xiu-fen Lei,et al.  Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. , 2006, Cancer research.

[30]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[31]  R. Iozzo,et al.  Decorin prevents metastatic spreading of breast cancer , 2005, Oncogene.

[32]  M. Klagsbrun,et al.  Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.

[33]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[34]  T. Yoneda,et al.  Crosstalk between cancer cells and bone microenvironment in bone metastasis. , 2005, Biochemical and biophysical research communications.

[35]  S. Parsons,et al.  c-Src and cooperating partners in human cancer. , 2004, Cancer cell.

[36]  H. Ozawa,et al.  Bone resorption induced by a metastatic human melanoma cell line. , 1995, Bone.